Sort
23,748 grants matching “melanoma”
Activation and Evasion of the Inflammasome by Noncytotoxic Staphylococcus aureus
$188,916Jordan B Jastrab · Brigham And Women'S Hospital · K08 · FY2025 · AI
Diagnosing Emergence of Kinase Inhibitor Resistance on a Microchip
$188,912Thomas G Graeber · University Of California Los Angeles · R21 · FY2013 · CA
Role of epidermis in regulating inflammatory skin manifestations of post-surgical lymphedema
$188,859Babak J Mehrara · Sloan-Kettering Inst Can Research · R21 · FY2024 · AR
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
$188,822Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2022 · CA
PRETARGETING STRATEGIES FOR CENTRAL NERVOUS MALIGNANCY RADIOIMMUNOTHERAPY
$188,805Duke University · P50 · FY2000 · NS
DNA Markers As Surrogates:Melanoma Patient Response
$188,800John Wayne Cancer Institute · R21 · FY2003 · CA
Smad3 inhibitors for ophthalmic applications
$188,750Ching Yuan · University Of Minnesota · R21 · FY2009 · EY
Protein Oxidation in Skin Cells by Tan Bed Irradiation
$188,700Ferris State University · R15 · FY2004 · ES
In Vivo Imaging Facility
$188,699Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
A mouse model for human gastrointestinal stromal tumor
$188,698Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
ROLE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS) IN ANGIOGENESIS
$188,661Peter C. Brooks · Mainehealth · P20 · FY2008 · RR
Targeting the suppressive immune microenvironment in leptomeningeal melanoma metastases
$188,644Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2022 · CA
Biostatistics Core
$188,640Phyllis A Gimotty · Wistar Institute · P01 · FY2010 · CA
Elucidating the role of tumor cell-intrinsic hypoxia inducible factor (HIF)-1α and HIF-2α pathway activation in tumor immune evasion
$188,592Jonathan A Trujillo · University Of Chicago · K08 · FY2024 · CA
Targeting Tumor Hypoxia with Radiohalogenated Inhibitors of Carbonic Anhydrase IX
$188,585John Louis Joyal · Molecular Insight Pharmaceuticals, Inc. · R21 · FY2011 · CA
Cancer Deep Phenotyping from Electronic Medical Records
$188,571Guergana K. Savova · Boston Children'S Hospital · U24 · FY2022 · CA
In Vivo Imaging Facility
$188,556Rivka R Colen · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA
In Vivo Imaging Facility
$188,556Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA
Elucidating the role of tumor cell-intrinsic hypoxia inducible factor (HIF)-1α and HIF-2α pathway activation in tumor immune evasion
$188,421Jonathan A Trujillo · University Of Chicago · K08 · FY2023 · CA
Gene Delivery Vehicles for Cancer Gene Therapy
$188,340University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy
$188,323Brent Allen Hanks · Duke University · R37 · FY2024 · CA
VALIDATION OF TRANSILLUMINATION AND THE NEVOSCOPE
$188,285Translite, Llc · R42 · FY2002 · CA
Discrete Sensor Devices for Determining Cancer Targets
$188,285Michael J Cima · Massachusetts Institute Of Technology · U54 · FY2014 · CA
Purchase of a Seahorse Bioscience XF Analyzer
$188,255Maureen E Murphy · Wistar Institute · S10 · FY2017 · OD
CORE 3: Bioinformatics
$188,236Ivan P Gorlov · University Of New Mexico Health Scis Ctr · P01 · FY2019 · CA